b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31062276</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>21</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>21</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">2107-0180</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>44</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Dec</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>European journal of drug metabolism and pharmacokinetics</Title>\n                <ISOAbbreviation>Eur J Drug Metab Pharmacokinet</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Current Understanding of the Equivalence Evaluations for In Vitro Tests on Generic Dry Powder Inhaler Drug Products in Japan.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>743-745</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13318-019-00561-z</ELocationID>\n            <Abstract>\n                <AbstractText>The Japanese Ministry of Health, Labour and Welfare issued the basic principles for bioequivalence evaluations of generic dry powder inhaler (DPI) drug products in 2016. This document presents the recommendations of the methodology for the effective development of generic DPI drug products. Based on this document, the Pharmaceuticals and Medical Devices Agency (PMDA) advises the efficient development in the consultation meeting with generic companies. The PMDA generally requires the data of in vitro tests, pharmacokinetics studies, and clinical endpoint studies for generic development. In vitro tests play a critical role in the development of the generic versions because these tests are used to predict the efficacy and safety of other populations on whom clinical endpoint studies have not been conducted. We are aware that some points need further discussion, such as the recommendations for at least four groups of stages (group 1: the induction port and pre-separator, group 2: greater than 5\xc2\xa0\xce\xbcm, group 3: ranging from 3 to 5\xc2\xa0\xce\xbcm, group 4: ranging from 0.8 to 3\xc2\xa0\xce\xbcm) for in vitro tests of the generic DPI products. This article shows the current understanding and recommendations with respect to in vitro tests, particularly for at least four groups of stages.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Kuribayashi</LastName>\n                    <ForeName>Ryosuke</ForeName>\n                    <Initials>R</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6778-7114</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Myoenzono</LastName>\n                    <ForeName>Aya</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Takagi</LastName>\n                    <ForeName>Kazunori</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hirota</LastName>\n                    <ForeName>Mitsue</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016422">Letter</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>France</Country>\n            <MedlineTA>Eur J Drug Metab Pharmacokinet</MedlineTA>\n            <NlmUniqueID>7608491</NlmUniqueID>\n            <ISSNLinking>0378-7966</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016568">Drugs, Generic</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016568" MajorTopicYN="Y">Drugs, Generic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058995" MajorTopicYN="N">Dry Powder Inhalers</DescriptorName>\n                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>\n                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013810" MajorTopicYN="Y">Therapeutic Equivalency</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>8</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31062276</ArticleId>\n            <ArticleId IdType="doi">10.1007/s13318-019-00561-z</ArticleId>\n            <ArticleId IdType="pii">10.1007/s13318-019-00561-z</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Aerosol Med. 2005 Winter;18(4):439-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16379619</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2018 Feb 20;13(2):e0193082</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29462195</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):217-224</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28848933</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Am Thorac Soc. 2017 Jul;14(7):1103-1107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28481631</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chest. 1991 Oct;100(4):1106-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1914568</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Allergy. 2005 Jan;60(1):23-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15575926</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacokinet. 2017 Mar;56(3):225-233</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27461251</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mater Sociomed. 2012;24(2):100-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23678316</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2004 Aug 21-27;364(9435):709-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15325838</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'